Chinta, S. J., Rajagopalan, S., Ganesan, A., & Andersen, J. K. (2012). A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson's Disease. Hindawi Publishing Corporation.
Citação norma ChicagoChinta, Shankar J., Subramanian Rajagopalan, Abirami Ganesan, and Julie K. Andersen. A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use As a Therapeutic for Parkinson's Disease. Hindawi Publishing Corporation, 2012.
ציטוט MLAChinta, Shankar J., Subramanian Rajagopalan, Abirami Ganesan, and Julie K. Andersen. A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use As a Therapeutic for Parkinson's Disease. Hindawi Publishing Corporation, 2012.